|
|
Article: Ceragenix Announces Promising Antimicrobial Coating Data.
- Article from:
- Business Wire
- Article date:
- December 3, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DENVER -- Ceragenix Pharmaceuticals, Inc. (OTCB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology today announced that recent in vitro testing has shown that its Cerashield[TM] antimicrobial coating applied to endotracheal tube segments was able to completely prevent bacterial adhesion and biofilm formation in a 14 day continuous challenge with 10E6 of Pseudomonas aeruginosa.
In this test procedure, both uncoated and Cerashield[TM] coated tube segments were exposed to daily challenges of 1 million colony forming units per ml of Pseudomonas aeruginosa in nutrient media broth. The broth was changed on a daily basis and fresh inocula ...